TY  - JOUR 
AU  - Novillo, Apolonia
AU  - Gaibar Alonso, María
AU  - Romero-Lorca, Alicia
AU  - Gilsanz, Maria Fuencisla
AU  - Beltrán, Laura
AU  - Galán, Miguel
AU  - Antón, Beatriz
AU  - Malón, Diego
AU  - Moreno, Amalia
AU  - Fernández-Santander, Ana
PY  - 2020
SN  - 1007-9327
UR  - http://hdl.handle.net/20.500.12020/1822
AB  - Background: In metastatic colorectal cancer (mCRC), the anti-vascular endothelial growth factor drug bevacizumab (BVZ) plus chemotherapy significantly improves progression-free survival compared to chemotherapy (CT) alone. This benefit is not,...
LA  - en
PB  - Springer
TI  - Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
DO  - http://dx.doi.org/10.3748/wjg.v26.i16.1979
T2  - World Journal Gastroenterology
M2  - 1979
KW  - Colorectal cancer
KW  - Bevacizumab
KW  - Chemokine CXCL5
KW  - Gene expression
KW  - Progression-free survival
KW  - Case report
VL  - 26
ER  -